Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medipal HoldingsMEPDF 81 3-Year Dividend Growth Rate is 12.80% as of Mar. 2026, which is 27% above its 10-year median of 10.10. GuruFocus rates MEPDF with a GF Score™ of 81/100 and a GF Value™ of $17.73 (Fairly Valued). The stock has 3 warning signs investors should review. Among 53 Medical Distribution companies, Medipal Holdings ranks better than 67.92% on this metric.
The historical rank and industry rank for Medipal Holdings's 3-Year Dividend Growth Rate or its related term are showing as below:
MEPDF'
s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0 Med: 10.1 Max: 44.2
Current: 12.8
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Medipal Holdings was 44.20% per year. The lowest was 0.00% per year. And the median was 10.10% per year.
MEPDF's 3-Year Dividend Growth Rate is ranked better than 67.92% of 53
companies
in the Medical Distribution industry
Industry Median: 5.4
vs MEPDF: 12.80
During the past 12 months, Medipal Holdings's average Dividends Per Share Growth Rate was 6.50% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 12.80% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 10.70% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 8.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest Dividend Payout Ratio of Medipal Holdings was 0.40. The lowest was 0.24. And the median was 0.29.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Medipal Holdings Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 34.000000
2026-03-30
2026-03-31
2026-06-02
Cash Dividend
semi-annually
JPY:USD 0.006286
JPY 32.000000
2025-09-29
2025-09-30
2025-12-02
Cash Dividend
semi-annually
JPY:USD 0.006758
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Medipal Holdings's Dividend Yield (%) for Today is calculated as
Current Share Price is $18.35.
Medipal Holdings's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.42998.
During the past 13 years, the highest Dividend Yield of Medipal Holdings was 2.77%. The lowest was 1.32%. And the median was 2.01%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medipal Holdings 3-Year Dividend Growth Rate Related Terms>
MEPDF vs MCK, COR, CAH: 3-Year Dividend Growth Rate Comparison
For the Medical Distribution subindustry, Medipal Holdings's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings 3-Year Dividend Growth Rate vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's 3-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Dividend Growth Rate of 12.80% mean?
Medipal Holdings (MEPDF) has a 3-Year Dividend Growth Rate of 12.80% as of Mar. 2026. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Medipal Holdings and its competitors. This is 27% above median its historical median of 10.10. According to the industry distribution chart, Medipal Holdings ranks #17 out of 53 companies in the Medical Distribution industry, placing it in the top 32.1%.
Is Medipal Holdings' 3-Year Dividend Growth Rate too high?
Medipal Holdings' current 3-Year Dividend Growth Rate of 12.80% is 27% above median its 10-year median of 10.10. The Medical Distribution industry median 3-Year Dividend Growth Rate is 5.40. Medipal Holdings' value of 12.80% is 137% above this industry median. Based on the distribution chart, Medipal Holdings ranks #17 out of 53 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Medipal Holdings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' 3-Year Dividend Growth Rate compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medipal Holdings ranks #17 out of 53 companies for 3-Year Dividend Growth Rate. This puts Medipal Holdings in the upper half of its industry. The industry median 3-Year Dividend Growth Rate is 5.40. Medipal Holdings' value of 12.80% is 137% above this benchmark. While the company's 10-year median is 10.10 vs. the industry median of 5.40, Medipal Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Medical Distribution company?
The median 3-Year Dividend Growth Rate among Medical Distribution companies is 5.40, based on 53 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medipal Holdings's current 3-Year Dividend Growth Rate of 12.80% is 137% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Medipal Holdings and its competitors. For the Medical Distribution industry, the median 3-Year Dividend Growth Rate is 5.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medipal Holdings's current 3-Year Dividend Growth Rate is 12.80%, which is 27% above median its own 10-year median of 10.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MEPDF) is currently considered Fairly Valued. The stock's GF Value™ is $17.73, compared to a current price of $18.35 — trading 3.5% above its estimated fair value. The current 3-Year Dividend Growth Rate is 12.80%, which is 27% above median its 10-year median of 10.10 and 137% above the Medical Distribution industry median of 5.40. Medipal Holdings' overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For Medipal Holdings (MEPDF), the current 3-Year Dividend Growth Rate is 12.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (MEPDF) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued.
The current stock price of $18.35 is trading 3.5% above its estimated GF Value™ of $17.73.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for MEPDF:
3-Year Dividend Growth Rate: 12.80% (27% above median its 10-year median of 10.10)
GF Value™: $17.73 vs. price of $18.35 (3.5% above fair value)
Industry Position: 137% above the Medical Distribution median (#17 of 53)
No single metric tells the full story. See the MEPDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
81GF Score
Get the complete analysis for MEPDF
3-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEPDF has been successfully added to your 
